We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
36 hedge funds and large institutions have $1.61M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
7% less capital invested
Capital invested by funds: $1.73M → $1.61M (-$115K)
8% less funds holding
Funds holding: 39 → 36 (-3)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
13
Closed
3
Calls
$484K
Puts
–
Net Calls
+$484K
Net Calls Change
-$47K
Top Buyers
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$73.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$40.2K |
| 3 |
Morgan Stanley
New York
|
-$19.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$14.4K |
| 5 |
Renaissance Technologies
New York
|
-$5.82K |
